App from SAMHSA guides medication treatment for opioid dependence | Addiction Professional Magazine Skip to content Skip to navigation

App from SAMHSA guides medication treatment for opioid dependence

December 1, 2016
by Gary A. Enos, Editor
| Reprints

A new mobile app for treatment professionals from the Substance Abuse and Mental Health Services Admninistration (SAMHSA) serves as a guide to medication-assisted treatment for opioid use disorders, including information on the process for becoming certified to prescribe buprenorphine.

MATx, available on the Apple app store and Google Play, includes information on the three federally approved medications for the treatment of opioid dependence. It also offers clinical support tools such as treatment guidelines, ICD-10 coding, and strategies for working with special populations.

“This free app supports practitioners who currently provide medication-assisted treatment, as well as those who plan to do so in the future,” according to a fact sheet from SAMHSA.



Of all the pains during our lives, the emotional pains are the worst of all pain! People are known to end their lives just to escape the pain of the emotional pain. We saw this with the actor Robin Williams who although made every one laugh but could not relieve his own emotional pain. Buprenorphine might have helped him.
Therefore Buprenorphine can prevent accidental deaths caused by overdosing heroin for the purpose of the relief of emotional pain. While on Buprenorphine therapy a person has a chance to lessen his or her emotional pain through counselling and ultimately have a chance of complete recovery.

There are perhaps many physicians who did not have a formal training of Internship and Residency or have not passed the certification by ASAM Examination but are prescribing Buprenorphine for 100 patients. Can the SAMAHSA set up an examinations for such physicians so that they can also be able to see 275 patients. It will be helpful if SAMAHSA can design an on line course for such physicians.